Owlstone Medical CEO discusses recent trends, the advantages of breath testing, and the challenges that must be met for wider clinical use.
Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.
Congress is renewing its previous efforts to make Medicare reimbursement of pharmacy testing permanent—here’s what that could mean for labs.
The inexpensive POC device is a biosensor that performs COMT genotyping as a biomarker for hypnotizability.
Principal investigator discusses a new research initiative to create a low-cost, rapid HIV self-test.